HUP0201485A3 - Mag expression promoters - Google Patents
Mag expression promotersInfo
- Publication number
- HUP0201485A3 HUP0201485A3 HU0201485A HUP0201485A HUP0201485A3 HU P0201485 A3 HUP0201485 A3 HU P0201485A3 HU 0201485 A HU0201485 A HU 0201485A HU P0201485 A HUP0201485 A HU P0201485A HU P0201485 A3 HUP0201485 A3 HU P0201485A3
- Authority
- HU
- Hungary
- Prior art keywords
- expression promoters
- mag expression
- mag
- promoters
- expression
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Psychiatry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Compounds Of Unknown Constitution (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP14433699 | 1999-05-25 |
Publications (2)
Publication Number | Publication Date |
---|---|
HUP0201485A2 HUP0201485A2 (en) | 2002-08-28 |
HUP0201485A3 true HUP0201485A3 (en) | 2004-01-28 |
Family
ID=15359751
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0201485A HUP0201485A3 (en) | 1999-05-25 | 2000-05-25 | Mag expression promoters |
Country Status (21)
Country | Link |
---|---|
US (2) | US7166630B2 (hu) |
EP (1) | EP1186296B1 (hu) |
KR (1) | KR100660955B1 (hu) |
CN (1) | CN1160072C (hu) |
AT (1) | ATE359780T1 (hu) |
AU (1) | AU774471B2 (hu) |
BG (1) | BG106254A (hu) |
BR (1) | BR0011551A (hu) |
CA (1) | CA2373967A1 (hu) |
CZ (1) | CZ20014203A3 (hu) |
DE (1) | DE60034448D1 (hu) |
EE (1) | EE200100621A (hu) |
HK (1) | HK1044721A1 (hu) |
HU (1) | HUP0201485A3 (hu) |
IL (1) | IL146726A0 (hu) |
IS (1) | IS6173A (hu) |
MX (1) | MXPA01012188A (hu) |
NO (1) | NO20015733L (hu) |
NZ (1) | NZ516261A (hu) |
RU (1) | RU2241454C2 (hu) |
WO (1) | WO2000071119A1 (hu) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1354664B1 (de) | 2002-04-20 | 2010-11-17 | Haas Laser GmbH & Co. KG | Einrichtung zur Überwachung eines optischen Elements eines Bearbeitungskopfes einer Maschine zur thermischen Bearbeitung eines Werkstücks |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19541146A1 (de) | 1995-10-25 | 1997-04-30 | Schering Ag | Imidazolderivate und deren Verwendung als Stickstoffmonoxid-Synthase-Inhibitoren |
BR9612316A (pt) * | 1995-12-27 | 1999-07-13 | Yoshitomi Pharmaceutical | Agente para profilaxia e tratamento de complicações diabéticas |
-
2000
- 2000-05-25 IL IL14672600A patent/IL146726A0/xx unknown
- 2000-05-25 RU RU2001134893/15A patent/RU2241454C2/ru not_active IP Right Cessation
- 2000-05-25 BR BR0011551-7A patent/BR0011551A/pt not_active IP Right Cessation
- 2000-05-25 EP EP00931568A patent/EP1186296B1/en not_active Expired - Lifetime
- 2000-05-25 CN CNB008092354A patent/CN1160072C/zh not_active Expired - Fee Related
- 2000-05-25 AT AT00931568T patent/ATE359780T1/de not_active IP Right Cessation
- 2000-05-25 KR KR1020017015051A patent/KR100660955B1/ko not_active IP Right Cessation
- 2000-05-25 CZ CZ20014203A patent/CZ20014203A3/cs unknown
- 2000-05-25 EE EEP200100621A patent/EE200100621A/xx unknown
- 2000-05-25 WO PCT/JP2000/003373 patent/WO2000071119A1/ja active IP Right Grant
- 2000-05-25 HU HU0201485A patent/HUP0201485A3/hu unknown
- 2000-05-25 CA CA002373967A patent/CA2373967A1/en not_active Abandoned
- 2000-05-25 MX MXPA01012188A patent/MXPA01012188A/es unknown
- 2000-05-25 NZ NZ516261A patent/NZ516261A/xx unknown
- 2000-05-25 AU AU49497/00A patent/AU774471B2/en not_active Ceased
- 2000-05-25 DE DE60034448T patent/DE60034448D1/de not_active Expired - Lifetime
-
2001
- 2001-11-23 IS IS6173A patent/IS6173A/is unknown
- 2001-11-23 NO NO20015733A patent/NO20015733L/no unknown
- 2001-12-20 BG BG106254A patent/BG106254A/xx unknown
-
2002
- 2002-08-29 HK HK02106416.1A patent/HK1044721A1/zh unknown
-
2004
- 2004-10-22 US US10/969,885 patent/US7166630B2/en not_active Expired - Fee Related
-
2006
- 2006-08-07 US US11/499,785 patent/US20060270712A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
NO20015733L (no) | 2002-01-11 |
MXPA01012188A (es) | 2003-06-30 |
RU2241454C2 (ru) | 2004-12-10 |
IL146726A0 (en) | 2002-07-25 |
AU4949700A (en) | 2000-12-12 |
WO2000071119A1 (fr) | 2000-11-30 |
CZ20014203A3 (cs) | 2002-06-12 |
BR0011551A (pt) | 2002-04-02 |
HK1044721A1 (zh) | 2002-11-01 |
AU774471B2 (en) | 2004-07-01 |
EP1186296A4 (en) | 2004-12-22 |
NZ516261A (en) | 2003-11-28 |
US20050090531A1 (en) | 2005-04-28 |
EP1186296A1 (en) | 2002-03-13 |
NO20015733D0 (no) | 2001-11-23 |
ATE359780T1 (de) | 2007-05-15 |
US7166630B2 (en) | 2007-01-23 |
CN1356900A (zh) | 2002-07-03 |
KR20020015332A (ko) | 2002-02-27 |
CA2373967A1 (en) | 2000-11-30 |
US20060270712A1 (en) | 2006-11-30 |
EP1186296B1 (en) | 2007-04-18 |
EE200100621A (et) | 2003-02-17 |
DE60034448D1 (de) | 2007-05-31 |
IS6173A (is) | 2001-11-23 |
CN1160072C (zh) | 2004-08-04 |
KR100660955B1 (ko) | 2006-12-26 |
BG106254A (en) | 2002-08-30 |
HUP0201485A2 (en) | 2002-08-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60027722D1 (en) | Aspartyl-protease inhibitoren | |
SG97811A1 (en) | Fluxing adhesive | |
IL148218A0 (en) | New phenylpiperazines | |
GB9903584D0 (en) | Modified calycins | |
GB9914210D0 (en) | Promoter | |
GB9919462D0 (en) | Hydrocyclone | |
GB9902598D0 (en) | A suspension arrangement | |
GB9906447D0 (en) | Suspension arrangements | |
GB2358869B (en) | Adhesion promoters | |
GB2371332B (en) | Independent suspension | |
HK1048307A1 (zh) | 取代的雜環基-2h-苯並吡喃類化合物 | |
GC0000254A (en) | 1-Trifluoromethyl-4-hydroxy-7-piperioinyl-aminomethylchroman derivaties | |
DE60012212D1 (en) | Orthotopisches totalkunstherz | |
AU6064301A (en) | Ectocornea extension promoters | |
EP1077257A4 (en) | LIGHT RESTRICTED PROMOTER | |
GB9911247D0 (en) | Senescence promoters | |
GB9911456D0 (en) | Oligohydroxyl substituted 3-urea-benzofurane-and-pyridofurane-derivatives | |
EP1174511A4 (en) | PROMOTERS | |
HUP0201485A3 (en) | Mag expression promoters | |
GB9911458D0 (en) | Cycloalkyl substituted 3-urea-benzofurane-and-pyridofurane-derivatives | |
PL352101A1 (en) | Substituted phenylcyclohexanocarboxyamides | |
GB9905498D0 (en) | Expression | |
EP1146123A4 (en) | MEGSINE PROMOTER | |
HUP0201126A3 (en) | Tapetum-specific promoters | |
EP1219303A4 (en) | PROMOTERS OF CHONDROGENESE |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD9A | Lapse of provisional protection due to non-payment of fees |